Skip to content

Efficacy evaluation of systemic glucocorticoids in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease in different phenotypes

Efficacy evaluation of systemic glucocorticoids in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease in different phenotypes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17013257
Enrollment
Unknown
Registered
2017-11-06
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

all patients except for those in exclusion criteria item 2:intravenous use methylprednisolone 40mg qd for 5 days
all patients:observation

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with acute respiratory failure due to acute exacerbation of COPD and under invasive mechanical ventilation treatment in ICU; 2. Male or Female aged more than 40 years; 3. Voluntary participation, understanding test contents and signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications with glucocorticoid and inappropriate for the use of hormones; (1) Long-term regular use of systemic glucocorticoid; (2) Combined with other serious respiratory diseases, such as pulmonary fibrosis, pulmonary embolism, pulmonary tumor, etc.; (3) Other conditions that the researchers considered unsuitable for inclusion; 2. The equivalent cumulative amount of total glucocorticoid >250mg of prednisone in the last 2 weeks, have already treated > 48h or the cumulative dose = 80mg prednisone before entering this study.

Design outcomes

Secondary

MeasureTime frame
Mechanical ventilation free days;Reintubation rate;Length of ICU stay;Length of hospital stay;Hospital mortality;

Primary

MeasureTime frame
Invasive mechanical ventilation free days;

Countries

China

Contacts

Public ContactLiang Zongan

West China Hospital, Sichuan University

liangzongan@126.com+86 028 85422377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026